Concepedia

Cost-Effectiveness Analysis: Lymph Node Transfer vs Lymphovenous Bypass for Breast Cancer-Related Lymphedema

Yurie Sekigami, Sydney Char, Cate Mullen, Kathryn E. Huber, Yu Cao, Rachel J. Buchsbaum, Roger A. Graham, Salvatore Nardello, Dhruv Singhal, Abhishek Chatterjee

Journal of the American College of Surgeons · 2021 · 20 citations · 16 references

DOI

Abstract

LNT is a dominant, cost-effective strategy compared to LVB for the treatment of BCRL.

References

16

Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold

Scott D. Grosse · Expert Review of Pharmacoeconomics & Outcomes Research · 2008 · 639 citations

, , +15

Incidence, Treatment Costs, and Complications of Lymphedema After Breast Cancer Among Women of Working Age: A 2-Year Follow-Up Study

Ya‐Chen Tina Shih, Ying Xu, Janice N. Cormier et al. · Journal of Clinical Oncology · 2009 · 478 citations · Full text

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

Don Husereau, Michael Drummond, Stavros Petrou et al. · Cost Effectiveness and Resource Allocation · 2013 · 387 citations · Full text

, , +5

Interpreting the Results of Cost-Effectiveness Studies

David J. Cohen, Matthew R. Reynolds · Journal of the American College of Cardiology · 2008 · 293 citations · Full text

, , +10

Microsurgery for lymphedema: Clinical research and long‐term results

Corradino Campisi, Carlo Bellini, C. Campisi et al. · Microsurgery · 2010 · 224 citations